On this episode, we're sharing the considerations of a phased approach to re-entry in the workplace.

In this episode, we're sharing our initial observations and reflections on the coronavirus pandemic.

On this episode, we discuss advancements in telehealth and how health systems can adopt it in specialty areas.

On this episode, we discuss the intersection of social determinants of health and financial health.

On this episode, we discuss the creation of healthy cultures through lean transformation and the climate of change within the healthcare industry that aligns with lean transformation efforts.

On this episode, we discuss the role technology is playing in global access to care.

On this episode, we discuss well-being - a combination of physical, mental, and spiritual health - in the workplace, and why it matters.

On this episode, we're looking beyond Electronic Health Records to discuss ways to extend their capabilities and value far beyond the original intent.

On this episode, we dive into the topic of clinical trials and how innovation is making its way into this critical function between a pharmaceutical company and the provider settings.

In 2017 the US spent an estimated 450 billion dollars on prescription drugs, about 12% of the total healthcare spending. With public and political uproar surrounding the life sciences industry pricing practices, we ask “why is drug pricing so comp